The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Bell, Laura
    Chief Financial Officer born in March 1982
    Individual (9 offsprings)
    Officer
    2023-07-24 ~ now
    OF - Director → CIF 0
  • 2
    Slater, Christopher James
    Managing Director - Commercial Operations born in January 1982
    Individual (8 offsprings)
    Officer
    2023-07-24 ~ now
    OF - Director → CIF 0
  • 3
    INHOCO 520 LIMITED - 1996-07-23
    Nunn Brook Road, Huthwaite, Sutton-in-ashfield, Nottinghamshire, United Kingdom
    Active Corporate (4 parents, 5 offsprings)
    Person with significant control
    2023-09-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 8
  • 1
    Burbank, Jeffrey H
    Ceo Nxstage Medical Inc born in June 1962
    Individual
    Officer
    2013-03-13 ~ 2022-09-01
    OF - Director → CIF 0
  • 2
    Brown, Robert S.
    Svp & Cfo, Nxstage Medical Inc. born in February 1959
    Individual
    Officer
    2011-11-22 ~ 2013-07-31
    OF - Director → CIF 0
  • 3
    Mazzei, Antony
    Director born in April 1982
    Individual (1 offspring)
    Officer
    2023-07-24 ~ 2024-12-10
    OF - Director → CIF 0
  • 4
    Miller, Jr., Michael
    President, International, Nxstage Medical, Inc. born in November 1957
    Individual
    Officer
    2011-11-22 ~ 2013-02-01
    OF - Director → CIF 0
  • 5
    Valle, William Joseph
    Company Director born in October 1960
    Individual
    Officer
    2019-09-24 ~ 2023-08-29
    OF - Director → CIF 0
  • 6
    Towse, Matthew W
    Chief Financial Officer born in August 1962
    Individual
    Officer
    2013-07-31 ~ 2019-05-22
    OF - Director → CIF 0
  • 7
    350, Merrimack Street, Lawrence, Massachusetts, United States
    Corporate
    Person with significant control
    2016-04-06 ~ 2023-09-01
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 8
    21, Holborn Viaduct, London, United Kingdom
    Active Corporate (5 parents, 259 offsprings)
    Officer
    2011-11-22 ~ 2022-03-10
    PE - Secretary → CIF 0
parent relation
Company in focus

NXSTAGE MEDICAL UK, LTD.

Standard Industrial Classification
82990 - Other Business Support Service Activities N.e.c.
85590 - Other Education N.e.c.
86900 - Other Human Health Activities
Brief company account
Average Number of Employees
22023-01-01 ~ 2023-12-31
22022-01-01 ~ 2022-12-31
Turnover/Revenue
8,869,869 GBP2023-01-01 ~ 2023-12-31
9,878,543 GBP2022-01-01 ~ 2022-12-31
Cost of Sales
-9,506,835 GBP2023-01-01 ~ 2023-12-31
-8,836,890 GBP2022-01-01 ~ 2022-12-31
Gross Profit/Loss
-636,966 GBP2023-01-01 ~ 2023-12-31
1,041,653 GBP2022-01-01 ~ 2022-12-31
Administrative Expenses
701,812 GBP2023-01-01 ~ 2023-12-31
-670,997 GBP2022-01-01 ~ 2022-12-31
Operating Profit/Loss
64,846 GBP2023-01-01 ~ 2023-12-31
370,656 GBP2022-01-01 ~ 2022-12-31
Equity
Retained earnings (accumulated losses)
1,738,619 GBP2023-12-31
1,788,860 GBP2022-12-31
1,594,872 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-50,241 GBP2023-01-01 ~ 2023-12-31
193,988 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment
5,185,373 GBP2022-12-31
Total Inventories
1,760,891 GBP2022-12-31
Debtors
Current
6,416,448 GBP2023-12-31
2,097,349 GBP2022-12-31
Cash at bank and in hand
135,141 GBP2023-12-31
606,237 GBP2022-12-31
Current Assets
6,551,589 GBP2023-12-31
4,464,477 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-3,495,520 GBP2023-12-31
-6,100,856 GBP2022-12-31
Net Current Assets/Liabilities
3,056,069 GBP2023-12-31
-1,636,379 GBP2022-12-31
Total Assets Less Current Liabilities
3,056,069 GBP2023-12-31
3,548,994 GBP2022-12-31
Net Assets/Liabilities
3,056,069 GBP2023-12-31
3,106,310 GBP2022-12-31
Equity
Called up share capital
1,317,450 GBP2023-12-31
1,317,450 GBP2022-12-31
Equity
3,056,069 GBP2023-12-31
3,106,310 GBP2022-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-316,652 GBP2023-01-01 ~ 2023-12-31
150,065 GBP2022-01-01 ~ 2022-12-31
Profit/Loss on Ordinary Activities Before Tax
64,846 GBP2023-01-01 ~ 2023-12-31
370,656 GBP2022-01-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
16,212 GBP2023-01-01 ~ 2023-12-31
70,425 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
8,309,594 GBP2022-12-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
-8,309,594 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
3,124,221 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
428,635 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-3,552,856 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Plant and equipment
5,185,373 GBP2022-12-31
Finished Goods/Goods for Resale
1,760,891 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
593,267 GBP2023-12-31
1,981,981 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
5,812,654 GBP2023-12-31
Other Debtors
Current
10,527 GBP2023-12-31
115,368 GBP2022-12-31
Trade Creditors/Trade Payables
Current
5,700 GBP2023-12-31
271,487 GBP2022-12-31
Amounts owed to group undertakings
Current
2,395,189 GBP2023-12-31
26,599 GBP2022-12-31
Corporation Tax Payable
Current
431,739 GBP2023-12-31
26,603 GBP2022-12-31
Taxation/Social Security Payable
Current
646,296 GBP2023-12-31
Other Creditors
Current
596 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
16,000 GBP2023-12-31
5,776,167 GBP2022-12-31
Creditors
Current
3,495,520 GBP2023-12-31
6,100,856 GBP2022-12-31
Net Deferred Tax Liability/Asset
-442,684 GBP2022-12-31
-292,619 GBP2022-01-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
442,684 GBP2023-01-01 ~ 2023-12-31
-150,065 GBP2022-01-01 ~ 2022-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
-442,684 GBP2022-12-31
  • NXSTAGE MEDICAL UK, LTD.
    Info
    Registered number 07857151
    Nunn Brook Road, Huthwaite, Sutton-in-ashfield, Nottinghamshire NG17 2HU
    Private Limited Company incorporated on 2011-11-22 (13 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-21
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.